Are Gastroenterologists Less Tolerant of Treatment Risks than Patients? Benefit-Risk Preferences in Crohn's Disease Management

BACKGROUND: Crohn's disease is a serious and debilitating gastrointestinal disorder with a high, unmet need for new treatments. Biologic agents have the potential to alter the natural course of Crohn's disease but present known risks of potential serious adverse events (SAEs). Previous stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, F. Reed, Hauber, Brett, Siegel, Corey A., Hass, Steven, Sands, Bruce E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438243/
https://www.ncbi.nlm.nih.gov/pubmed/20866166
http://dx.doi.org/10.18553/jmcp.2010.16.8.616

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438243/
https://www.ncbi.nlm.nih.gov/pubmed/20866166
http://dx.doi.org/10.18553/jmcp.2010.16.8.616

Ejemplares similares